BioHealth News Archive
Personal Genome Diagnostics Welcomes New Members to Board of Directors, Bringing Proven, Industry-Leading Experience in Precision Medicine and Healthcare Policy
Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, announced today that it has added two new members to its Board of Directors,…
Read More
Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region · BioBuzz
For every AstraZeneca, there are hundreds of small biotech startups and scores of life science innovators that are critical to growing the BioHealth Capital…
Read More
New Blood Test for 8 Common Cancers – Johns Hopkins Medicine
Johns Hopkins researchers have developed a unique, noninvasive blood test that detects proteins and gene mutations from eight common cancers. The test, called CancerSEEK,…
Read More
New ebook: How Protenus fast-tracked hiring with a more focused strategy – Technical.ly Baltimore
In late 2017, Baltimore-based healthcare startup Protenus was reverberating from a year of growth. {iframe}https://technical.ly/baltimore/2019/02/26/new-ebook-how-protenus-fast-tracked-hiring-with-a-more-focused-strategy-startup-growth/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=70328335&_hsenc=p2ANqtz-_TNFdfueC5DC0OavXosIVf_lSA9LlKuLoRmxdm_VpX8pdGruXQn8vQC9XMxruXS8Qn7yRuTV7IODA_4H95vc2JyjDplQ&_hsmi=70328335{/iframe}
Read More
BioFactura CEO Dr. Darryl Sampey Shares his Entrepreneurial Journey at Frederick’s StartupGrind Event – BioBuzz
Dr. Darryl Sampey has been through the grind as CEO of Frederick’s BioFactura, a thriving biotech company that’s a key part of the BioHealth…
Read More
NexImmune raising $10M for AML drug trials – Washington Business Journal
The company has already raised about $40 million to date. {iframe}https://www.bizjournals.com/washington/news/2019/02/26/gaithersburg-biotech-raising-second-round-of.html{/iframe} https://www.bizjournals.com/washington/news/2019/02/26/gaithersburg-biotech-raising-second-round-of.html
Read More
Her biotech firm solves medical mysteries. (And no, it’s not Theranos.)
I was dubious when Crystal Icenhour approached me to write about her medical testing company. {iframe}https://www.washingtonpost.com/amphtml/business/economy/her-biotech-firm-solves-medical-mysteries-and-no-its-not-theranos/2019/02/22/3eb25b58-3554-11e9-af5b-b51b7ff322e9_story.html?noredirect=on{/iframe}
Read More
NCC-PDI Announces $250K Pediatric Pitch Competition for Orthopedic Medical Device Innovators
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) is now accepting applications for its "Make Your Medical Device Pitch for Kids!" competition. The…
Read More
This Viral Therapy Could Help Us Survive the Superbug Era
In November 2015, infectious disease epidemiologist Steffanie Strathdee and her husband, evolutionary psychologist Tom Patterson, were spending the week of Thanksgiving exploring pyramids and…
Read More
New study finds $9 billion in technology sales following NCI-funded research | TechLink
The National Cancer Institute’s investment in small business research grants has supported strong economic growth, including $9 billion in sales of new technologies. {iframe}https://techlinkcenter.org/new-study-finds-9-billion-in-technology-sales-following-nci-funded-research/{/iframe}
Read More
Want to raise $75M in funding? NEA investor explains how Baltimore’s PGDx did it – Baltimore Business Journal
Justin Klein, as a former investor with NEA, helped lead PGDx’s $21.4 million Series A in 2015 and its $75 million Series B last…
Read More
Roche Deal for Spark Therapeutics Shows Biotech M&A Spark Hasn’t Died – RealMoney
The biotech sector has been a strong performer in 2019 after becoming quite oversold during the plunge in the high-beta parts of the market…
Read More
Big exit alert: Roche to buy Philly’s Spark Therapeutics in $4.8B deal – Technical.ly Philly
In a $4.8 billion deal, Swiss life sciences giant Roche has agreed to acquire Spark Therapeutics, a University City-based developer of gene therapy treatment for genetic…
Read More
Top 10 Immuno-Oncology Startups – GEN – Genetic Engineering and Biotechnology News
GlaxoSmithKline (GSK)’s recently announced $4.2 billion partnership to co-develop and co-commercialize Merck KGaA, Darmstadt’s cancer immunotherapy candidate M7824 was a reminder of just how…
Read More
Danaher acquires GE Biopharma for $21.4B – Washington Business Journal
The deal is expected to close in the fourth quarter of this year. {iframe}https://www.bizjournals.com/washington/news/2019/02/25/danaher-acquires-ge-biopharma-business-for-21-4b.html?u=fQFLvOpMSMnvK7iAcBsVng0eb45ba2&t=1551113639&j=86879321{/iframe}
Read More